PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia |
Massachusetts General Hospital / Jessica Blackburn, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG |
Lucile Packard Children’s Hospital at Stanford University School of Medicine / Yujie Tang, PhD |
Young Investigator Grants |
2014 |
California |
Mechanisms of regulation of the PI#K/AKT pathway downstream of NOTCH1 in T-ALL.
|
Columbia University / Teresa Palomero, PhD |
Young Investigator Grants |
2007 |
New York |
Identification of Novel Treatment Targets by Exploring the Interaction of Rhabdomyosarcoma-Associated Oncogenes with Cellular Context in a Mouse Model of Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Simone Hettmer |
Young Investigator Grants |
2010 |
Massachusetts |
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan / Carl Koschmann, MD |
Young Investigator Grants |
2014 |
Michigan |
The Impact of Hypoxia on Epigenetic Changes in Neuroblastoma |
University of Chicago / Sakshi Uppal, PhD |
Young Investigator Grants |
2017 |
Illinois |
The Role of Germline Variants in Infant Leukemogenesis |
Washington University / Margaret Ferris, MD/PhD |
Young Investigator Grants |
2019 |
Missouri |
SWI/SNF Complex and Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Jennifer Wu |
Young Investigator Grants |
2012 |
Massachusetts |
High-throughput CAR NKT Library Screen for Improving Neuroblastoma Immunotherapy |
Baylor College of Medicine / Xavier Rios, MD/PhD |
Young Investigator Grants |
2020 |
Texas |
Dissecting the Mechanism of Overgrowth and Tumorigenesis in Beckwith-Wiedemann Syndrome |
University of Pennsylvania / Jennifer Kalish, MD, PhD |
Young Investigator Grants |
2013 |
Pennsylvania |